Alvotech is listed on Nasdaq for a public offering, targeting investors in the European Economic Area.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alvotech is listed on Nasdaq for a public offering, targeting investors in the European Economic Area.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alvotech
biotechnology company
-
Nasdaq
American fully electronic stock exchange
- Chainlink, Nasdaq, Depository Trust & Clearing Corporation, and New York Stock Exchange are partnering on a tokenization platform for clearing services related to real-world assets and equities.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.